Summary: H.R.2255 — 102nd Congress (1991-1992)All Information (Except Text)

There is one summary for H.R.2255. Bill summaries are authored by CRS.

Shown Here:
Introduced in House (05/08/1991)

Amends Federal patent law to extend the patent term for certain drugs composed of non-steroidal anti-inflammatory agents if during the regulatory review process the patentee: (1) filed a new drug application in 1982; (2) awaited approval by the Food and Drug Administration for at least 78 months, and (3) such new drug application was approved in 1988. Prescribes a formula for patent term extension, and sets forth administrative notification procedures.